Author

Anna Kopp

University of MichiganORCID 0000-0002-2799-4581Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Synthetic Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Greg M. ThurberiD· 2 shared Alec A. DesaiiD· 1 shared Andrew PhilippartiD· 1 shared Dong Jun KooiD· 1 shared Hyeyoung KwoniD· 1 shared Jennifer J. LindermaniD· 1 shared Jordan Vinh· 1 shared Marshall CaseiD· 1 shared

Activity by Year

2023-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

Greg M. ThurberORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioengineeringMolecular Cancer TherapeuticsPeer-reviewedDec 30, 2025

In vivo Auto-tuning of Antibody-Drug Conjugate Delivery for Effective Immunotherapy using High-Avidity, Low-Affinity Antibodies

Anna Kopp, Shujun Dong, Hyeyoung Kwon…·Greg M. Thurber

This study develops HALA antibodies that adjust ADC delivery based on tumor HER2 expression, improving efficacy across varying expression levels in preclinical models.

9 citations

mouseproteomics

𝕏 PostBluesky

Synthetic BiologybioRxivPreprintDec 5, 2023

Discovery of high affinity and specificity stapled peptide Bcl-xL inhibitors using bacterial surface display

Marshall Case, Jordan Vinh, Anna Kopp…·Greg M. Thurber

The paper develops high-affinity, specific stapled peptides that inhibit Bcl-xL, showing 10 nM affinity and 100-fold selectivity over other Bcl-2 family members.

DOI 10.1101/2023.12.05.570108

experimental assaydrug response / drug discovery

𝕏 PostBluesky